AstraZeneca

News

BMS lawsuit claims AZ's Imjudo infringes Yervoy patents

AstraZeneca followed a long and arduous road to bring its CTLA4 inhibitor Imjudo to market, and will now have to defend its new product from a patent infringement complaint brought by Brist

Digital

Ovarian cancer, Olivia, and the OCC – part one

Following the European Society of Gynaecological Oncology (ESGO) 2022 congress, pharmaphorum spoke with experts from among the Ovarian Cancer Commitment (OCC) founding partners – ESGO, the

News

AstraZeneca backs AI-based lung cancer diagnosis pilot in UK

Drugmaker AstraZeneca has teamed up with Indian digital health specialist Qure.ai and a clinical group in the UK to test an artificial intelligence-powered technology to help radiologists d

Digital

patient app and clinical trial support tool

Driving clinical trial innovation forward with precision med...

Late last year, pharmaphorum spoke with AstraZeneca’s Ben Challis, VP and head of translational science and experimental medicine, cardiovascular, renal, and metabolism (CVRM), together wit

News

EU clears AstraZeneca's new-form severe asthma drug Tezspire

AstraZeneca's first-in-class severe asthma therapy Tezspire has been approved in the EU in a new pen injector formulation suitable for administration by patients themselves.

News